Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
ConditionDry Eye Syndromes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity of Rochester
About this trial
This is a single center double-masked study with up to four visits. Subjects who have been diagnosed with dry-eye syndrome at Flaum Eye Institute will be enrolled. The purpose of the study is to determine if using platelet rich plasma drops can improve clinically significant dry eye in patients and determine if there is a difference with using two different uses of the plasma tear drops: platelet rich plasma tears and plasma tears without platelets.
Eligibility criteria
Qualifiers
Subjects must be diagnosed with clinically significant dry eye.
Subjects have no active ocular disease or allergic conjunctivitis.
Subjects must not be using any topical ocular medications within two weeks prior to enrollment.
Subjects must be willing and able to follow instructions.
Disqualifiers
Is pregnant at the time of enrolment in the study determined by urine pregnancy test.
Is currently on a course of antibiotics
Is considered by the Investigator to not be a suitable candidate for participation and are not at risk for glaucoma.
Is considered by the University of Rochester Transfusion Medicine & Blood Bank not a suitable candidate for blood donation.
Trial design
Treatments tested in this trial
- Platelet Poor Plasma Tear Drops
- Platelet Rich Plasma Tear Drops
Treatment groups
15 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov